And furthermore,
NICE conclusion states "long-term cost savings would be materialised only if adopting the test reduces the number of people who need end-stage renal failure treatments."
Now look what MSAC said:
"MSAC noted that the applicant also agreed to removing the retesting suggestions for people with moderate- or high-risk scores. Retesting would now be restricted to patients assessed as low-risk of developing DKD by the test and their retesting interval would be restricted to a minimum of four years."
Read that carefully, NICE said it would only save costs if it reduced the number of people who need end-stage renal failure, and then PIQ agreed with MSAC that they need to re-model their economic study to only test low risk patients.
There are so many inconsistencies with PromarkerD, you have Richard spinning marketing BS about 86% accuracy and high PPV but when you look at the clinical results from each of the studies, the PPV has widely different from 34% in one study to 74% in another. The underlying issue with PromarkerD is obvious - they need REAL WORLD clinical data and this is where Sonic will probably play a part. Sonic will provide the infrastructure to recruit and do a study to collect real world clinical data. This would explain why FDA submission has fallen by the way side. But the problem here is the patent expires in 2031!
- Forums
- ASX - By Stock
- PIQ
- Ann: PromarkerD application for Australian MBS to be resubmitted
Ann: PromarkerD application for Australian MBS to be resubmitted, page-37
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PIQ (ASX) to my watchlist
|
|||||
Last
88.5¢ |
Change
0.015(1.72%) |
Mkt cap ! $115.8M |
Open | High | Low | Value | Volume |
89.0¢ | 92.5¢ | 87.5¢ | $331.1K | 373.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 62734 | 88.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
90.0¢ | 25000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 62734 | 0.885 |
1 | 10000 | 0.880 |
4 | 90296 | 0.875 |
2 | 36780 | 0.870 |
2 | 4557 | 0.865 |
Price($) | Vol. | No. |
---|---|---|
0.900 | 25000 | 2 |
0.910 | 10000 | 1 |
0.930 | 10000 | 1 |
0.940 | 6263 | 2 |
0.950 | 5000 | 1 |
Last trade - 15.52pm 21/06/2024 (20 minute delay) ? |
Featured News
PIQ (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online